Skip to main content
Leanabl Logo

Planning and Feasibility · Usability Engineering (IEC 62366-1)

Engineer IEC 62366-1 & FDA Human Factors usability evidence that withstands regulatory scrutiny.

Global reviewers (FDA CDRH, EU Notified Bodies, MFDS) audit the entire lifecycle chain: Use Specification, Known Use Problems, PCA task analysis, Use-Related Risk Analysis (URRA) linked to ISO 14971, formative design iterations, summative validation (N≥15 per group), and Root Cause Analysis (RCA).

Domain Expertise

Deep regulatory authority across every medical device domain

SaMD · AI Digital Health

IEC 62304 & IEC 82304-1 Software Lifecycle · FDA PCCP & Good Machine Learning Practice

Multi-demographic dataset bias control and statistical validation design for Sensitivity, Specificity, and ROC-AUC

Active Devices · Robotics

IEC 60601-1 Ed. 3.2 & IEC 60601-1-2 Ed. 4.1 · IEC 60601-2-XX Particular Standards

Essential Performance definition and worst-case test matrix optimization across FDA, EU Notified Bodies, and MDSAP

Implants · Biomaterials

ISO 10993-1:2018 & ISO 10993-18 E&L · ISO 11135 / 11137 Sterilization & ISO 11607

Biological evaluation plans (BEP), ISO 10993-18 chemical characterization, and toxicological risk assessment (TRA)

In Vitro Diagnostics (IVD)

EU IVDR 2017/746 & FDA IVD Guidance · CLSI EP Guidelines (EP05, EP06, EP12, EP17, EP25)

CLSI-compliant Limit of Detection (LoD), precision, cross-reactivity, interference, and lot-to-lot reproducibility protocols

Proprietary Data & Precedent Validation

PCA Use-Error Hazard Library & Global Summative Protocol Benchmark DB

100% Traceability Across uFMEA Critical Tasks, ISO 14971 Controls & Summative Validation

Engineered 4-Stage Workflow

4-Stage Human Factors Pipeline from Use Spec to Summative UEF Delivery

Step 01 / 04Stage Gate & Output

Use Specification, Task Analysis, uFMEA & Critical Tasks Locked

Incomplete baseline data or misclassified regulatory pathways are the primary drivers of multi-month submission delays. Gate 01 locks the device scope, predicate/standard mapping, and full document inventory before authoring begins.

Verification Baseline

Device description, intended use, existing test reports, and QMS document index

Gate Sign-Off Output

Confirmed classification matrix and locked submission master inventory

Agentic Automation & Platform Integration

Synchronize Usability Risk Controls with ISO 14971 & Multi-Language eIFU

Bi-Directional Sync: uFMEA Critical Tasks ↔ ISO 14971 Risk File

Maintains a single source of truth between use-related hazards, severity ratings, UI design mitigations, and summative verification evidence.

@Risk Management— Run "Bi-Directional Sync: uFMEA Critical Tasks ↔ ISO 14971 Risk File" across our Usability Engineering (IEC 62366-1) records and call out the highest-priority compliance findings first.

I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.

Thought for 4.2s · Explored Risk Management records & 14 regulatory clauses

P1 · Verified Agent Output· Use Specification, Task Analysis, uFMEA & Critical Tasks Locked

Maintains a single source of truth between use-related hazards, severity ratings, UI design mitigations, and summative verification evidence. ISO 14971 risk register linked to design control

Audit-Ready Formative & Summative Observation Logs

Preserves participant task outcomes, close-call annotations, and Root Cause Analysis (RCA) narratives in a traceable digital repository.

@Requirements Management— Run "Audit-Ready Formative & Summative Observation Logs" across our Usability Engineering (IEC 62366-1) records and call out the highest-priority compliance findings first.

I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.

Thought for 4.3s · Explored Requirements Management records & 14 regulatory clauses

P1 · Verified Agent Output· Validated Safety Warnings ↔ Global eIFU Labeling Lock

Links summative-validated IFU instructions and warnings directly to Leanabl eIFU workflows to prevent unvalidated labeling edits. Traceability from specification to verification

Service Specification

Service Scope & Final Deliverables

Scope

Covers the entire human factors lifecycle from use-related risk analysis (uFMEA) to formative and summative validation reporting.

  • Use Specification authoring — user profiles, use environments, and primary operating functions
  • Task Analysis, PCA (Perception-Cognition-Action) use-error hazard analysis (uFMEA), and Critical Task identification
  • Bi-directional traceability between ISO 14971 risk controls and UI/alarm/IFU design mitigations
  • Formative evaluation and Summative human factors validation protocol engineering (aligned with IEC 62366-1 & FDA HFE guidance)
  • Simulated-use study execution, Root Cause Analysis (RCA) of use errors/close calls, and final HFE/UER report compilation

Deliverables

Audit-ready Usability Engineering Files structured for FDA eSTAR, EU MDR Notified Bodies, and global submissions.

  • Usability Engineering Plan (UEP) & Use Specification Document
  • Use-Related Risk Analysis (uFMEA) & Critical Task Selection Matrix
  • Formative & Summative Validation Protocols, Moderator Guides, and Data Capture Forms
  • Observed Use Error, Close Call & Root Cause Analysis (RCA) Dossier
  • Final Usability Engineering Report (UER / FDA HFE/UE Report) & ISO 14971 Traceability Matrix
Usability Engineering (IEC 62366-1) — Service Scope & Final Deliverables
CategoryItem / MilestoneSpecification & Deliverable
ScopeScope 1Use Specification authoring — user profiles, use environments, and primary operating functions
ScopeScope 2Task Analysis, PCA (Perception-Cognition-Action) use-error hazard analysis (uFMEA), and Critical Task identification
ScopeScope 3Bi-directional traceability between ISO 14971 risk controls and UI/alarm/IFU design mitigations
ScopeScope 4Formative evaluation and Summative human factors validation protocol engineering (aligned with IEC 62366-1 & FDA HFE guidance)
ScopeScope 5Simulated-use study execution, Root Cause Analysis (RCA) of use errors/close calls, and final HFE/UER report compilation
WorkflowStage 1: Use Specification & Use-Related Risk Analysis (uFMEA)Define intended user groups and environments, decompose tasks, and identify hazard-related use scenarios (Critical Tasks).
WorkflowStage 2: Formative Evaluation & UI Risk MitigationConduct cognitive walkthroughs and formative usability testing to refine hardware/software UI and labeling before design freeze.
WorkflowStage 3: Summative Validation Protocol & Simulated-Use TestingLock the summative validation protocol and execute simulated-use testing across representative user cohorts.
WorkflowStage 4: Root Cause Analysis (RCA) & Master UEF DeliveryAnalyze any observed use errors or close calls, justify residual use-related risk, and compile the final UEF / HFE Report.
DeliverablesDeliverable 1Usability Engineering Plan (UEP) & Use Specification Document
DeliverablesDeliverable 2Use-Related Risk Analysis (uFMEA) & Critical Task Selection Matrix
DeliverablesDeliverable 3Formative & Summative Validation Protocols, Moderator Guides, and Data Capture Forms
DeliverablesDeliverable 4Observed Use Error, Close Call & Root Cause Analysis (RCA) Dossier
DeliverablesDeliverable 5Final Usability Engineering Report (UER / FDA HFE/UE Report) & ISO 14971 Traceability Matrix

Frequently Asked Questions

When should usability engineering start?
As early as possible, ideally before interface decisions are locked. We can also review an existing usability file and identify what can still be strengthened before submission.
Do you review both formative and validation evidence?
Yes. We look at whether formative work explains design decisions and whether validation evidence supports safe use for the intended users and use environments.
Do you recruit participants or run studies?
Not within the base gap-analysis scope. Recruitment, facility coordination, study execution, and full report authoring can be scoped separately when needed.
Which standards and markets do you cover?
The core review is built around IEC 62366-1 logic and can be mapped to target-market expectations such as Korea, FDA human factors, EU MDR, or other local requirements.
How does Leanabl handle agency Additional Information (AI) requests or Notified Body deficiency letters during Usability Engineering (IEC 62366-1)?
Upon receiving any deficiency notice from FDA, an EU Notified Body, or an international review authority, our engineers dissect the reviewer’s finding against harmonized ISO/IEC clauses and clearance precedents. We separate items resolvable via technical justification from those requiring supplementary bench data, author the formal response dossier, and drive reviewer alignment through closure.
Can we structure one master DHF / IMDRF STED and test campaign to cover FDA, EU MDR, and APAC markets simultaneously?
Yes—that is the core advantage of our universal lifecycle engineering model. By harmonizing FDA eSTAR requirements, EU MDR Annex II/III GSPR checklists, IMDRF STED templates, and multi-country IECEE CB National Deviations before testing or authoring begins, we eliminate redundant laboratory campaigns and prevent region-by-region dossier rewrites.
We have a lean internal RA/QA team—how much bandwidth is required from our R&D engineers?
Our workflow is designed to protect your R&D velocity. Once your team provides baseline engineering inputs (specifications, BOM, architecture diagrams) during Stage 1 intake, Leanabl executes the heavy lifting: standard clause mapping, ISO 14971 risk traceability, regulatory authoring, and laboratory coordination. Your team only reviews and signs off at structured stage gates.
What happens if our hardware, firmware, or software changes during or after the engagement?
We immediately perform a multi-regime regulatory change impact assessment (covering FDA 510(k) modification guidance, EU MDR MDCG 2020-3 significant change criteria, and ISO 13485 design control) to determine whether a formal submission or internal Letter-to-File / QMS update is required. Because deliverables are modularized in our platform, only affected sections require updating.

Make the usability file reviewable before the reviewer sees it.

We separate missing evidence, weak traceability, and follow-on study work so the next step is clear before submission.